Glucose-6-phosphate isomerase
Glucose-6-phosphate isomerase
Glucose-6-phosphate isomerase (GPI), also known as phosphoglucose isomerase (PGI) or phosphohexose isomerase (PHI), is an enzyme that plays a crucial role in both the glycolysis and gluconeogenesis pathways. It catalyzes the reversible isomerization of glucose-6-phosphate to fructose-6-phosphate.
Function[edit]
GPI is a key enzyme in the glycolysis pathway, which is the process of breaking down glucose to produce energy in the form of ATP. In the gluconeogenesis pathway, GPI facilitates the formation of glucose from non-carbohydrate sources, ensuring a continuous supply of glucose during periods of fasting or intense exercise.
Structure[edit]
GPI is a dimeric enzyme, meaning it consists of two identical subunits. Each subunit has a molecular weight of approximately 60 kDa. The enzyme's active site is located at the interface of the two subunits, where the isomerization reaction takes place.
Mechanism[edit]
The isomerization reaction catalyzed by GPI involves the conversion of glucose-6-phosphate to fructose-6-phosphate. This reaction is essential for the continuation of the glycolysis pathway, as fructose-6-phosphate is further metabolized to produce pyruvate and ATP.
Clinical Significance[edit]
Mutations in the GPI gene can lead to a rare genetic disorder known as glucose-6-phosphate isomerase deficiency. This condition is characterized by chronic hemolytic anemia, as the red blood cells are unable to produce sufficient energy due to impaired glycolysis. Symptoms may include fatigue, jaundice, and an increased risk of infections.
Related Enzymes[edit]
GPI is part of a family of enzymes known as isomerases, which catalyze the conversion of one isomer to another. Other important isomerases in the glycolysis pathway include triosephosphate isomerase and phosphoglycerate mutase.
See Also[edit]
References[edit]
External Links[edit]
-
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
